Research Career Development Core (RCDC)


This Core, led by Paula Shireman, MD, MBA, and Peter Hornsby, PhD, promotes the career development of early-stage investigators. Accessing the research education, training and career development resources of UTHSCSA’s Institute for Integration of Medicine and Science (IIMS) and the robust and unique aging research resources and research education programs in South Texas, our Mentored Research Career Development (San Antonio OAIC RL5) Scholars are trained in the mechanisms that govern the aging process, and in the design of pre-clinical and clinical interventions for diseases and conditions that affect older adults. All San Antonio OAIC RL5 Scholars will have research projects, mentoring teams, and specific short- and long-term career goals. The RCDC also will sponsor various training and mentoring research experiences. UT Health and its partners offer a rich pool of available trainees and mentors, additional sources of career funding, laboratories, and multiple opportunities for didactic coursework. San Antonio OAIC RL5 scholars also are eligible for pilot support from the PESC.

Peter Hornsby, PhD, RCDC Core Co-Leader
Peter Hornsby, PhD,
RCDC Core Co-Leader
Paula Shireman, MD, MBA, RCDC Core Co-Leader
Paula Shireman, MD, MBA
RCDC Core Co-Leader

We plan to support cohorts of up to two San Antonio OAIC RL5 Scholars annually for up to two years per award. Leveraging the research education, training and career development resources of IIMS and the robust and unique aging research resources and research education programs in South Texas, the program enhances the clinical and translational research knowledge and experience of basic scientists, develop mechanistic research skills of clinical investigators, and facilitate collaborations among basic and clinical researchers.

New 2019 RL5 Scholar Position Available

The San Antonio Older Americans Independence Center (SA OAIC) at UT Health is soliciting applications for the Mentored Research Career Development Program. SA OAIC will have one or two new 12 month mentored research RL5 Scholar positions available beginning May 2019 or soon thereafter. Applications for these NIH funded positions are due February 25, 2019 at 11:59pm. The RL5 program targets early career faculty or individuals who are completing postdoctoral training with an impending academic appointment. Qualified candidates will hold a doctoral health professional degree (MD, etc.), or PhD, or equivalent degree, and have keen interest in careers that focus on clinical and/or translational research in the area of aging. Applicants are sought from all UT Systems Schools in San Antonio – UT Health Science Center, University of Texas at San Antonio, University of Texas College of Pharmacy (San Antonio campus), University of Texas School of Public Health, and Texas A&M University-San Antonio. Please see the RFA, Instructions and forms at the sidebar on this page.

Eligibility Information

San Antonio OAIC RL5 scholar applicants should be postdoctoral fellows transitioning to full-time academic faculty appointment or junior faculty members with a graduate or professional degree (e.g., M.D., D.D.S., Ph.D., R.N., M.P.H., Pharm.D.) All applicants must display evidence of high motivation, a pro-active work style, strong academic achievement and scholarship. Other eligibility requirements include:

  • Should be able to commit 50 to 75% full-time professional effort (6-9 calendar months) to the program and its related clinical/translational science research activities.
  • Dual employment by UTHSCSA and the VA may be restricted, depending upon the amount of VA effort. Federal salaries are not considered part of the suggested 50-75% San Antonio OAIC RL5 Scholar institutional commitment.
  • Applicants must not be, or have been, a Principal Investigator on a R01 or R21 award or a Project Leader on a subproject of a Program Project (P01), Center (P50, P60, U54) or other equivalent research grant award, or a Principal Investigator of a mentored research career development grant. Applicants may have received prior support on an Institutional or Individual NRSA grant (F or T) or NIH Small Grant (R03). Also, RL5 participants may receive salary support from other federal sources consistent with the institution’s salary scale as long as those sources do not specifically prohibit such salary supplementation. Nevertheless, individuals supported by NIH training and career development mechanisms (K, T, or F awards) may not receive salary or stipend supplementation from the RL5 program.

Terms of the Award (Annual)

  • Salary support of 50-75% of NIH salary cap + fringe
  • Scholarly travel support of $2,000
  • Research support of up to $25,000

Features of Training Experience

Program Entry: Scholars will be assessed to determine the competencies needed to move them forward to the next phase of their translational research career focused on aging. Each Scholar will work with a primary mentor and a multidisciplinary mentoring team, essential because Scholars must work with scientists making fundamental discoveries and with clinicians who provide for the needs of older adults with multiple co-morbidities. Milestones for each scholar will be developed that comprise the steps in his or her research project.

Program Progress: During the program, the multi-disciplinary Mentoring Team will monitor Scholar progress at quarterly group meetings. Progress will be measured and documented through written semi-annual self-evaluations with input from the primary mentor and committee.

Program Transition: Across the program there will be a focus on honing grant-seeking skills (e.g., individual career development awards), with activities including the KL2 Seminar Series – ‘Focus on Research Grant Excellence’ (FORGE) and Grant Writing with New Investigators (GWNI). As Scholars complete the program, each will be assisted with the next step of their career.

Core Activities: In addition to the IIMS/San Antonio OAIC RL5 Program curriculum, translational aging research focused training includes: ‘Introduction to Translational Science’ — provides a broad perspective on translational science processes from basic science discovery to population implementation and policy research; a clinical practicum with a San Antonio OAIC faculty member to learn principles of Geriatrics Assessment and measurement (especially important for individuals without prior geriatrics training); ‘Pharmacotherapy of Special Populations’ section related to older adults will provide instruction on drug utilization, impact, and evaluation.


2017-2019 San Antonio OAIC Scholars

Grace C. Lee, PharmD, PhD

Grace C. Lee, PharmD, PhD
Grace C. Lee, PharmD, PhD

Research Project: Metformin to improve vaccine response and prolong healthspan in the elderly

Grace C. Lee, PharmD, PhD, is an Assistant Professor with The University of Texas at Austin College of Pharmacy and Adjunct Professor with UT Health San Antonio. She received her Doctor of Pharmacy degree from the University of the Pacific, Thomas J. Long School of Pharmacy. After completing her residency training, Dr. Lee began her position as an infectious diseases pharmacist at Kaiser Permanente in Northern California where she helped establish a regional antimicrobial stewardship program. In 2016, Dr. Lee received her PhD in Translational Science through a joint program between UT Health San Antonio, UT Austin, and the University of Texas San Antonio. Dr. Lee joined the UT Austin faculty in Fall 2016. Dr. Lee’s research has focused on the prevention and management of infectious diseases in older adults. Her RL5 project aims to determine whether metformin can improve the immune response to pneumococcal vaccines in older adults.

Miranda E. Orr, PhD

Miranda E. Orr, PhD
Miranda E. Orr, PhD

Research project: The Effects of NAD Modulation on Cognitive Aging

Miranda E. Orr, PhD is an Instructor at UT Health San Antonio in the Department of Pharmacology and Barshop Institute for Longevity and Aging Studies. Dr. Orr’s research focuses on cognitive aging and Alzheimer’s disease pathogenesis. She earned her PhD in Neuroscience through a joint dissertation between Montana State University and the McLaughlin Research Institute for Biomedical Research, a mouse genetics facility renowned for their neurodegenerative disease mouse models. As a predoctoral student, she was a recipient of an NIA F31 Individual Predoctoral Fellowship, National Research Service Award and NIH COBRE Center for Structural and Functional Neuroscience Award. Her work provided fundamental evidence for the utility of “patient derived stem cells” to study Alzheimer’s disease pathogenesis. In 2012, Dr. Orr earned a postdoctoral position on the NIA T32 Biology of Aging Training Grant at the Barshop Institute. She gained expertise in testing cognitive behavior and pharmacological interventions in Alzheimer’s disease mouse models, and investigated mechanisms of healthy brain aging using the longest-lived rodent known, the naked mole-rat. In 2016, Dr. Orr joined the UT Health faculty. She recently received two awards, one for basic research: Nathan Shock Transformative Pilot Award in Basic Aging, and one for translational research: Claude D. Pepper Center Pilot Award. Dr. Orr is using these resources to apply discoveries in basic science to human studies, which is the foundation of her RL5 project. Preclinical research has demonstrated that sustained NAD(+) levels is critical for the maintenance of healthy brain aging and overall lifespan in animal models. During her RL5, Dr. Orr will test whether therapies that boost NAD(+) levels can enhance cognition in healthy older individuals and those with cognitive impairment. Through this program, Dr. Orr will continue her pursuit in attaining her long-term career goal: find interventions that improve brain aging, and ultimately discover effective treatments for Alzheimer’s disease.

Lisa Kilpela, PhD

Lisa Kilpela, PhD
Lisa Kilpela, PhD

Research project: Healthy Weight Intervention Among Aging Women: An Investigation into the Role of Aging on Intervention Efficacy

Lisa Smith Kilpela, PhD, is an Assistant Professor in the Department of Psychiatry at UT Health San Antonio, and is a member of the Research to Advance Community Health (ReACH) Center. Dr. Kilpela is a licensed clinical psychologist, and she received her PhD in clinical psychology from Emory University. She completed her clinical internship at Duke University Medical Center and her postdoctoral research fellowship at Trinity University on a multi-site R01 investigating eating disorders prevention in athletes. Dr. Kilpela’s research focuses on the assessment, prevention, and treatment of eating and weight disorders. Her previous research includes investigation into the base rates and negative health consequences of dysregulated eating behaviors and body dissatisfaction in women across the lifespan. Dr. Kilpela is particularly interested in the evaluation and treatment of dysregulated eating and weight control behaviors in older populations, as well as negative health and wellness outcomes associated with these behaviors. The primary objectives of her project are to: 1) identify the unique psychological, behavioral, and endocrinological characteristics associated with dysregulated eating and weight control behaviors in older women, including health/wellness correlates (e.g., sleep, exercise, mood, quality of life); and 2) investigate the efficacy, acceptability, and feasibility of a behavioral intervention for dysregulated eating among older women.

Dr. Kilpela’s selection as a San Antonio OAIC scholar reflects the Center’s dedication to the identification of efficacious and effective interventions to improve the health, wellness, and longevity of older Americans.

2015-2017 San Antonio OAIC Scholars

Corinna Ross, PhD

Corinna Ross, PhD
Corinna Ross, PhD

Research Project: The effects of chronic rapamycin treatment on motor and cognitive functionin a nonhuman primate model of aging, common marmosets.

Dr. Ross is a basic scientist with a career trajectory that is leading to an emphasis on translational research, with a clear connection to clinical research in aging. Her career development plan reflects this position. Her project continues her ongoing work and moves more centrally to the theme of emphasis of the San Antonio OAIC.

The work builds on the observations made earlier in mice, that a pure pharmaceutical, rapamycin, can reproducibly extend lifespan. This seminal observation set in motion a vast array of investigations in many labs. In particular, it became evident that it would be essential to study rapamycin in nonhuman primates. Whatever the fundamental mechanisms of action of rapamycin, it will be necessary to show that these mechanisms work in primates. In primates investigational studies can be done that are impossible in humans. Therefore there is a clear path from basic observations on standard lab model organisms via nonhuman primates to human subjects.

Sukeshi Patel, MD

Sukeshi Patel, MD
Sukeshi Patel, MD

Research Project: A study to evaluate proteostasis modulation with histone deacetylase (HDAC) inhibitors as potential aging modulating agents in cancer patients.

In this project, Dr. Patel is studying the action of a histone deacetylase (HDAC) inhibitor on indicators of the rate of aging in patients with metastatic colorectal cancer.

Dr. Patel represents an important developing area at UTHSCSA, geriatric oncology. While cancer strikes the older population disproportionately, most basic and clinical studies in cancer research are of younger individuals. It is vital to understand the changing biology of cancer in older individuals and to appreciate how these changes impact the effectiveness of therapeutic strategies. Moreover, an emerging concept is that drugs used to treat cancer may act as “gerontogens” – named by analogy with carcinogens, to indicate compounds that can actually cause aging, or change the basic rate of aging.

Dr. Patel’s selection as a OAIC KL2 scholar recognizes that clinician-scientists will be needed to advance the field of geriatric oncology by bridging the gap between basic biology (of both aging and cancer) and the clinical approach to the treatment of cancer in the older individual. Understanding the full potential of the action of chemotherapeutic drugs will need this breadth of understanding.

Kelly Reveles, PharmD, PhD 

Kelley Reveles, PharmD, PhD
Kelly Reveles, PharmD, PhD

Research Project: Comparison of gut microbiota composition and inflammation in elderly proton pump inhibitor-users and non-users.

Dr. Reveles’ selection as a San Antonio OAIC Scholar reflects the focus of the Center on pharmacological interventions as modulators of human biology that may impact the rate of aging. The unique aspect of this focus is the potential modulation of aging via the gut microbiota. The importance of the microbiota in all aspects of human biology is now being fully realized. Interactions between gut bacteria and diet constituents (including pharmaceuticals) influence many aspects of the immune, endocrine and other physiological systems. Simultaneously these physiological systems can regulate the microbiota. The extensive interactions between the microbiota and the human body are beginning to be realized, but the full extent remains to be discovered. It is quite within the bounds of possibility that we will find that the microbiota actually affect fundamental aging processes – indeed, in C. elegans there is already evidence that this occurs.

The second focus of Dr. Reveles’ research is the class of drugs known as proton pump inhibitors, PPIs, available over the counter and consumed in huge amounts by Americans. The increasing use of these drugs is fueled by the prevailing assumption that long term use of these drugs is safe. However, the lack of stomach acid secondarily affects the colonization of the small intestine by bacteria and subsequently affects the much larger number of bacteria in the colon. The long-term consequences are unknown. Changes to a less favorable mix of species resulting from the change in stomach acid could conceivably have multiple long term adverse effects that involve fundamental aging processes, as Dr. Reveles describes in her project.